Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Fuhrmann G

Helmholtz-Centre for Infection Research, Braunschweig, Germany Helmholtz-Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany

Biography

Helmholtz-Centre for Infection Research, Braunschweig, Germany

Helmholtz-Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany

Saarland University, Saarbrücken, Germany
He is ahaving experience in all the areas Biomaterials, Nanobiotechnology, Controlled Drug Delivery, Biomaterial Engineering, Biocompatibility, Nanoparticle Preparation, Biodegradable Polymers, Pharmaceutical Formulation, Polymers, Nanomaterials

Publications

Quo Vadis, Cardio-Oncology?

Nebigil CG, Tounsi N, Fuhrmann G and Désaubry L

Short Communication: Adv Oncol Res Treat 2016. 1:1

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top